TABLE 1.
Effect of C. trachomatis serovars E and LGV on the extent of tyrosine phosphorylation in human spermatozoa assessed by indirect immunofluorescence
| Treatmenta | Proportion of spermatozoa displaying fluorescence (%)b |
|---|---|
| NCap | 12.5 ± 2.0 |
| Cap | 26.8 ± 2.1c |
| Cap+E | 45.7 ± 2.1cd |
| Cap+LGV | 30.8 ± 2.5ce |
a
NCap, noncapacitated spermatozoa; Cap, capacitated spermatozoa; Cap+E, spermatozoa capacitated with serovar E; Cap+LGV, spermatozoa capacitated with serovar LGV.
b
The results are presented as means ± standard errors of the means (n = 12, with 100 spermatozoa scored for each treatment). These values were analyzed by one-way ANOVA.
c
Significantly different from noncapacitated spermatozoa (P < 0.001).
d
Significantly different from capacitated spermatozoa (P < 0.01).
e
Not significantly different from capacitated spermatozoa (P > 0.05).